Home » Topics » Regulatory » EMA

EMA
RSS

EMA launches improved version of EudraVigilance system for safety monitoring

Nov. 22, 2017

EMA announces relocation to the Netherlands

Nov. 21, 2017

Orexo's Zubsolv approved for opioid dependence in Europe

Nov. 21, 2017

bb-2121 receives FDA breakthrough therapy and EMA PRIME designations

Nov. 17, 2017

Marketing applications for volanesorsen accepted in U.S., E.U. and Canada

Nov. 16, 2017

EMA grants Motrem access to PRIME scheme for septic shock

Nov. 15, 2017

EMA's CHMP issues positive opinion on Adcetris for CTCL

Nov. 15, 2017

EMA committee supports approval of Endoceutics' Intrarosa

Nov. 15, 2017

EMA grants accelerated assessment to patisiran for hereditary ATTR amyloidosis

Nov. 14, 2017

EMA grants orphan drug designation to Debio-1347

Nov. 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...